The existing range of oncology products includes products for treating neuro-oncological and haematological malignancies.

The product range includes:


Depocyte® (liposomal cytarabine) - A sustained-release injectable formulation of cytarabine for the treatment of lymphomatous meningitis, a serious late-stage complication of lymphoma.


Levactâ–¼®/Ribomustin®/Ribovact® (bendamustine) - A novel chemotherapy agent for certain types of multiple myeloma, chronic lymphocytic leukaemia (CLL) and indolent non-Hodgkin’s lymphoma.


Folotyn® (pralatrexate injection) - A folate analogue metabolic inhibitor in development for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL).

Key facts

Related links